Cat. No. 3763
Chemical Name: 1-[1-(1-Methylcyclooctyl)-4-piperid
Biological ActivityHigh affinity NOP receptor agonist (pKi = 10.07 for the human NOP receptor). Exhibits anxiolytic effects with no effect on memory or locomotion. Regarded as one of the most potent, non-peptide NOP full agonists in vitro.
Licensing InformationSold for research purposes under agreement from Pfizer Inc.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Hayashi et al (2009) Novel non-peptide nociceptin/orphanin FQ receptor agonist, 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole: design, synthesis, and structure-activity relationship of oral receptor occupancy in the brain for orally potent antianxiety drug. J.Med.Chem. 52 610. PMID: 19125610.
Hirao et al (2008) Pharmacological characterization of the newly synthesized nociceptin/orphanin FQ-receptor agonist 1-[1-(1-methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole as an anxiolytic agent. J.Pharmacol.Sci. 106 361. PMID: 18319566.
If you know of a relevant reference for MCOPPB trihydrochloride please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses MCOPPB trihydrochloride from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: MCOPPB trihydrochloride, supplier, MCOPPB, trihydrochloride, antianxiety, anxiolytic, NOP, receptor, full, agonist, Tocris Bioscience, NOP Receptor Agonist products
Find multiple products by catalog number
New Products in this Area
Fluorescent opioid antagonist; fluorescent-derivative of naloxone (Cat. No. 0599)
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.